Mariola Söhngen
Chief Executive Officer at PROTEOME SCIENCES PLC
Profile
Mariola Söhngen is the founder of Bootcamp (founded in 1999) and PAION AG (founded in 2000).
She is also the founder of Paion Deutschland GmbH.
Currently, Dr. Söhngen is the Chief Executive Officer & Executive Director at Proteome Sciences Plc since 2020.
Previously, she held the position of Chief Executive Officer at Convert Pharmaceuticals SA from 2018 to 2019.
She also served as the Chief Medical Officer at PAION AG from 2011 to 2015.
Other former positions include Managing Director at W.
Söhngen GmbH, Head-Research & Development at MOLOGEN AG from 2015 to 2018, Manager at Grünenthal GmbH from 1988 to 1996, and Head-Clinical Research at Trommsdorff GmbH & Co. KG from 1997 to 1998.
Dr. Söhngen has also been a Member-Supervisory Board at Vita 34 AG.
She has a scientific background and worked as a Scientist at Fachhochschule Düsseldorf.
Dr. Söhngen completed her undergraduate and doctorate degrees at RWTH Aachen University.
Mariola Söhngen active positions
| Companies | Position | Start |
|---|---|---|
| PROTEOME SCIENCES PLC | Chief Executive Officer | 2020-09-14 |
Former positions of Mariola Söhngen
| Companies | Position | End |
|---|---|---|
Convert Pharmaceuticals SA
 Convert Pharmaceuticals SA Miscellaneous Commercial ServicesCommercial Services Convert Pharmaceuticals SA provides preclinical stage drug development services. Its product hypoxia activated prodrug (HAP) is a therapeutic obstacle as it promotes the development of resistance to conventional anti-cancer treatments. The company was founded by Philippe Lambin, Nicolas Geuens, and Paul Tulcinsky on February 24, 2017 and is headquartered in Liege, Belgium. | Chief Executive Officer | 2019-11-30 |
| MOLOGEN AG | Chief Executive Officer | 2018-07-30 |
| PAION AG | Founder | 2015-10-30 |
Trommsdorff GmbH & Co. KG
 Trommsdorff GmbH & Co. KG Pharmaceuticals: MajorHealth Technology Trommsdorff GmbH & Co. KG engages in the manufacture, development, and distribution of pharmaceuticals, as well as nutritional and dietary supplements. It also sells medical equipment and devices. The company is headquartered in Alsdorf, Germany. | Chief Tech/Sci/R&D Officer | 1997-12-31 |
Grünenthal GmbH
 Grünenthal GmbH Pharmaceuticals: MajorHealth Technology Grünenthal GmbH engages in the research and development of pharmaceutical products. It specializes in pain, gout, and inflammation. The company was founded by Hermann Wirtz in 1946 and is headquartered in Aachen, Germany. | Corporate Officer/Principal | 1995-12-31 |
Training of Mariola Söhngen
| RWTH Aachen University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| PAION AG | Health Technology |
| PROTEOME SCIENCES PLC | Health Technology |
| MOLOGEN AG | Commercial Services |
| VITA 34 AG | Health Technology |
| Private companies | 6 |
|---|---|
Grünenthal GmbH
Grünenthal GmbH Pharmaceuticals: MajorHealth Technology Grünenthal GmbH engages in the research and development of pharmaceutical products. It specializes in pain, gout, and inflammation. The company was founded by Hermann Wirtz in 1946 and is headquartered in Aachen, Germany. | Health Technology |
Paion Deutschland GmbH
 Paion Deutschland GmbH BiotechnologyHealth Technology Paion Deutschland GmbH engages in the development of pharmaceutical products. The company is headquartered in Aachen, Germany. | Health Technology |
Trommsdorff GmbH & Co. KG
Trommsdorff GmbH & Co. KG Pharmaceuticals: MajorHealth Technology Trommsdorff GmbH & Co. KG engages in the manufacture, development, and distribution of pharmaceuticals, as well as nutritional and dietary supplements. It also sells medical equipment and devices. The company is headquartered in Alsdorf, Germany. | Health Technology |
Convert Pharmaceuticals SA
Convert Pharmaceuticals SA Miscellaneous Commercial ServicesCommercial Services Convert Pharmaceuticals SA provides preclinical stage drug development services. Its product hypoxia activated prodrug (HAP) is a therapeutic obstacle as it promotes the development of resistance to conventional anti-cancer treatments. The company was founded by Philippe Lambin, Nicolas Geuens, and Paul Tulcinsky on February 24, 2017 and is headquartered in Liege, Belgium. | Commercial Services |
| Bootcamp | |
W. Söhngen GmbH
 W. Söhngen GmbH Medical SpecialtiesHealth Technology W. Söhngen GmbH engages in the development, production, and distribution of medical kits. It offers products for wound care as well as first aid and emergency medicine. The company is headquartered in Taunusstein, Germany. | Health Technology |
- Stock Market
- Insiders
- Mariola Söhngen
